Hexagon Nutrition has scheduled its 33rd Annual General Meeting for September 22, 2026, alongside reporting its strongest-ever financial performance for FY2025-26, with consolidated profit after tax rising 56% year-on-year to ₹379.37 million.
The company has also intimated the distribution of web-links for its Integrated Annual Report to members without registered email addresses, ensuring access to the notice convening the AGM and the annual report for FY26.
FY26 Financial Highlights
The company's consolidated revenue from operations grew 17.8% year-on-year to ₹3,826.28 million in FY2025-26, compared to ₹3,249.29 million in FY2024-25. Profitability expanded well ahead of revenue, with EBITDA rising 32.0% to ₹529 million and EBITDA margin widening to 13.8% from 12.3% in the prior year. PAT margin improved to 9.9% from 7.5%.
| Metric |
FY2025-26 |
FY2024-25 |
Change |
| Revenue from Operations (₹ mn) |
3,826.28 |
3,249.29 |
+17.8% |
| EBITDA (₹ mn) |
529 |
401 |
+32.0% |
| EBITDA Margin (%) |
13.8 |
12.3 |
+150 bps |
| Profit After Tax (₹ mn) |
379.37 |
243.05 |
+56.1% |
| PAT Margin (%) |
9.9 |
7.5 |
+240 bps |
| Basic EPS (₹) |
3.43 |
1.75 |
+96.0% |
| Return on Equity (%) |
17.8 |
10.8 |
+700 bps |
| Net Debt/Equity (times) |
0.13 |
0.14 |
— |
On a standalone basis, revenue from operations stood at ₹3,191.20 million versus ₹2,674.47 million in FY2024-25, with standalone PAT at ₹381.48 million compared to ₹269.69 million.
Segment Performance
The company operates across three segments. The branded nutrition (B2C) segment delivered year-on-year growth of 23.74%, crossing the ₹1,000 million mark. The premix formulations (B2B2C) segment grew 31% overall, with domestic premix up 44.06% and export premix up 24.87%. The ESG segment declined 16.51% due to delays in tender releases.
| Segment |
Revenue (₹ mn) |
Share (%) |
| Branded Nutrition (B2C) |
1,139.56 |
30 |
| Premix Formulations (B2B2C) |
2,026.48 |
53 |
| ESG Segment |
649.95 |
17 |
Export revenue contributed approximately 57% of total FY26 revenue, with the company exporting to 80+ countries across five continents.
IPO Listing and Corporate Developments
Hexagon Nutrition listed on the NSE and BSE on June 12, 2026, through a 100% Offer for Sale of 3,08,59,704 equity shares at an issue price of ₹45 per share, aggregating to ₹138.87 crore. The IPO was subscribed 53.68 times overall, with the QIB portion subscribed 19.77 times, NII 161.49 times, and retail 26.85 times. The listing price was ₹48.25 per share on NSE and ₹48.00 per share on BSE.
During the year, Hexagon Nutrition (Exports) Private Limited was amalgamated with the company pursuant to an NCLT order dated January 14, 2026, with an appointed date of April 1, 2025.
Dividend and AGM Agenda
The Board has recommended a final dividend of ₹0.30 per equity share of face value ₹1 each for FY2025-26, subject to shareholder approval at the AGM. The record date for dividend eligibility is September 15, 2026, and the dividend payment date is between September 23, 2026 and October 22, 2026.
The 33rd AGM will be held on Tuesday, September 22, 2026 at 11:30 am (IST) through video conferencing. Key resolutions include adoption of financial statements, re-appointment of Dr. Nikhil Arun Kelkar as Joint Managing Director, declaration of the final dividend, appointment of Raghunath Sawant as Executive Director, revision in remuneration of executive directors, and alteration of the Articles of Association.
| AGM Detail |
Particulars |
| Date |
September 22, 2026 |
| Time |
11:30 am IST |
| Mode |
Video Conferencing / OAVM |
| Record Date |
September 15, 2026 |
| Remote e-Voting Period |
September 19, 2026 (9:00 am) to September 21, 2026 (5:00 pm) |
Members who have not registered their email addresses can access the Annual Report and AGM Notice via the web-link provided by the company. The exact path is Investors → Annual Report → Hexagon Nutrition Limited → Annual Report 2025-26 on the company website.
Key Financial Ratios
| Ratio |
FY2025-26 |
FY2024-25 |
| Current Ratio (times) |
3.38 |
3.50 |
| Return on Capital Employed (%) |
20.9 |
17.1 |
| Net Worth (₹ mn) |
2,333 |
1,942 |
| Debt Service Coverage Ratio |
1.89 |
1.52 |
The company's R&D expenditure for FY26 stood at ₹18.35 million. Foreign exchange inflows were ₹1,498.79 million and outflows were ₹660.91 million during the year.